Zobrazeno 1 - 10
of 988
pro vyhledávání: '"Lucas CM"'
Autor:
Lucas CM; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Harvard Medical School Blavatnik Institute of Global Health and Social Medicine, Boston, Massachusetts, USA., Mack MC; Division of Pediatric Hematology-Oncology, University of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA., Majeski J; Supportive and Palliative Care and Trauma Programs, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA., Maurer SH; Division of Pediatric Hematology-Oncology, University of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Division of Palliative Medicine & Supportive Care, University of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Sep; Vol. 71 (9), pp. e31167. Date of Electronic Publication: 2024 Jul 04.
Autor:
Lucas CM; Boston Children's Hospital, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA., Seguin C; UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.; University of Pittsburgh, Pittsburgh, PA, USA.
Publikováno v:
Clinical pediatrics [Clin Pediatr (Phila)] 2024 Mar 15, pp. 99228241237913. Date of Electronic Publication: 2024 Mar 15.
Autor:
Di Mambro A; School of Life and Health Sciences, University of Roehampton, London, UK., Arroyo-Berdugo Y; School of Life and Health Sciences, University of Roehampton, London, UK., Fioretti T; CEINGE Biotecnologie Avanzate, Via Gaetano Salvatore, Napoli, Italy., Randles M; Chester Centre for Leukaemia Research, Chester Medical School, University of Chester, Chester, UK., Cozzuto L; Centre Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain., Rajeeve V; Barts Cancer Institute, Queen Mary University of London, London, UK., Cevenini A; CEINGE Biotecnologie Avanzate, Via Gaetano Salvatore, Napoli, Italy.; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy., Austin MJ; Barts Cancer Institute, Queen Mary University of London, London, UK., Esposito G; CEINGE Biotecnologie Avanzate, Via Gaetano Salvatore, Napoli, Italy.; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy., Ponomarenko J; Centre Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.; University Pompeu Fabra (UPF), Barcelona, Spain., Lucas CM; Chester Centre for Leukaemia Research, Chester Medical School, University of Chester, Chester, UK., Cutillas P; Barts Cancer Institute, Queen Mary University of London, London, UK., Gribben J; Barts Cancer Institute, Queen Mary University of London, London, UK., Williams O; Great Ormond Street Institute of Child Health London, UCL, London, UK., Calle Y; School of Life and Health Sciences, University of Roehampton, London, UK., Patel B; Barts Cancer Institute, Queen Mary University of London, London, UK., Esposito MT; School of Life and Health Sciences, University of Roehampton, London, UK. mariateresa.esposito@surrey.ac.uk.; School of Biosciences, University of Surrey, Guildford, UK. mariateresa.esposito@surrey.ac.uk.
Publikováno v:
Oncogene [Oncogene] 2023 Dec; Vol. 42 (50), pp. 3670-3683. Date of Electronic Publication: 2023 Oct 27.
Autor:
Valdivia HO; U.S. Naval Medical Research Unit No. 6 (NAMRU-6), Lima, Peru., Anderson K; Australia Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia.; QIMR-Berghofer Medical Research Institute, Brisbane, Australia., Smith D; Australia Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia.; QIMR-Berghofer Medical Research Institute, Brisbane, Australia., Pasay C; Australia Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia.; QIMR-Berghofer Medical Research Institute, Brisbane, Australia., Salas CJ; U.S. Naval Medical Research Unit No. 6 (NAMRU-6), Lima, Peru., Braga G; U.S. Naval Medical Research Unit No. 6 (NAMRU-6), Lima, Peru., Lucas CM; U.S. Naval Medical Research Unit No. 6 (NAMRU-6), Lima, Peru., Lizewski SE; U.S. Naval Medical Research Unit No. 6 (NAMRU-6), Lima, Peru., Joya CA; U.S. Naval Medical Research Unit No. 6 (NAMRU-6), Lima, Peru., Kooken JM; Australia Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia.; Walter Reed Army Institute for Research, Silver Spring, USA., Sanchez JF; U.S. Naval Medical Research Unit No. 6 (NAMRU-6), Lima, Peru. juan.sanchez209.ln@health.mil., Cheng Q; Australia Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia. Qin.Cheng@defence.gov.au.; QIMR-Berghofer Medical Research Institute, Brisbane, Australia. Qin.Cheng@defence.gov.au.
Publikováno v:
Scientific reports [Sci Rep] 2022 Nov 18; Vol. 12 (1), pp. 19845. Date of Electronic Publication: 2022 Nov 18.
Autor:
Mary-Lauyé AL; Laboratorio de Ecología Fluvial, Departamento de Ciencias Biológicas, CENUR Litoral Norte - Universidad de La República, Km 363, Ruta 3, 6000, Paysandú, Paysandú, Uruguay., González-Bergonzoni I; Laboratorio de Ecología Fluvial, Departamento de Ciencias Biológicas, CENUR Litoral Norte - Universidad de La República, Km 363, Ruta 3, 6000, Paysandú, Paysandú, Uruguay., Gobel N; Laboratorio de Ecología Fluvial, Departamento de Ciencias Biológicas, CENUR Litoral Norte - Universidad de La República, Km 363, Ruta 3, 6000, Paysandú, Paysandú, Uruguay., Somma A; Laboratorio de Ecología Fluvial, Departamento de Ciencias Biológicas, CENUR Litoral Norte - Universidad de La República, Km 363, Ruta 3, 6000, Paysandú, Paysandú, Uruguay., Silva I; Laboratorio de Ecología Fluvial, Departamento de Ciencias Biológicas, CENUR Litoral Norte - Universidad de La República, Km 363, Ruta 3, 6000, Paysandú, Paysandú, Uruguay., Lucas CM; Laboratorio de Ecología Fluvial, Departamento de Ciencias Biológicas, CENUR Litoral Norte - Universidad de La República, Km 363, Ruta 3, 6000, Paysandú, Paysandú, Uruguay. clucas@litoralnorte.udelar.edu.uy.
Publikováno v:
Environmental monitoring and assessment [Environ Monit Assess] 2022 Nov 07; Vol. 195 (1), pp. 80. Date of Electronic Publication: 2022 Nov 07.
Autor:
Maynara Santana Gonçalves, Maria Carolina Oliveira, Daniela A. Moraes, Joao Rodrigues Lima Junior, Julia Tc Azevedo, Lucas Cm Arruda, Kelen Cr Malmegrim, Dimas Tadeu Covas
Publikováno v:
SATURDAY, 15 JUNE 2019.
Background Autologous hematopoietic stem cell transplantation (AHSCT) is nowadays a clinical reality as an effective and safe approach to treat systemic sclerosis patients’ refractory to conventional therapy using immune suppressive drugs, although
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afa6fd1536032593e7b3b2694645a549
https://doi.org/10.1136/annrheumdis-2019-eular.2863
https://doi.org/10.1136/annrheumdis-2019-eular.2863
Autor:
Mäkelä E; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; Turku Doctoral Programme of Molecular Medicine, University of Turku, Turku, Finland.; Institute of Biomedicine, University of Turku, Turku, Finland., Pavic K; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland., Varila T; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland., Salmenniemi U; Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland., Löyttyniemi E; Department of Biostatistics, University of Turku, Turku, Finland., Nagelli SG; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; Drug Research Doctoral Programme, University of Turku, Turku, Finland., Ammunét T; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland., Kähäri VM; Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland., Clark RE; Department of Molecular, Clinical and Cancer Medicine, University of Liverpool, Liverpool, England, United Kingdom., Elo LL; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.; Institute of Biomedicine, University of Turku, Turku, Finland., Bachanaboyina VK; Chester Medical School, University of Chester, Chester, England, United Kingdom., Lucas CM; Department of Molecular, Clinical and Cancer Medicine, University of Liverpool, Liverpool, England, United Kingdom.; Chester Medical School, University of Chester, Chester, England, United Kingdom., Itälä-Remes M; Department of Hematology, Turku University Hospital, Turku, Finland., Westermarck J; Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland. jukwes@utu.fi.; Institute of Biomedicine, University of Turku, Turku, Finland.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 May 15; Vol. 27 (10), pp. 2848-2860. Date of Electronic Publication: 2021 Mar 05.
Autor:
Jobbins AM; Leicester Institute of Structural & Chemical Biology and Department of Molecular & Cell Biology, University of Leicester, Leicester, UK., Campagne S; Institute of Biochemistry, ETH Zürich, Switzerland., Weinmeister R; Leicester Institute of Structural & Chemical Biology and Department of Molecular & Cell Biology, University of Leicester, Leicester, UK.; Leicester Institute of Structural & Chemical Biology and Department of Chemistry, University of Leicester, Leicester, UK., Lucas CM; Leicester Institute of Structural & Chemical Biology and Department of Molecular & Cell Biology, University of Leicester, Leicester, UK., Gosliga AR; Leicester Institute of Structural & Chemical Biology and Department of Molecular & Cell Biology, University of Leicester, Leicester, UK., Clery A; Institute of Biochemistry, ETH Zürich, Switzerland., Chen L; Leicester Institute of Structural & Chemical Biology and Department of Molecular & Cell Biology, University of Leicester, Leicester, UK., Eperon LP; Leicester Institute of Structural & Chemical Biology and Department of Molecular & Cell Biology, University of Leicester, Leicester, UK., Hodson MJ; Leicester Institute of Structural & Chemical Biology and Department of Molecular & Cell Biology, University of Leicester, Leicester, UK., Hudson AJ; Leicester Institute of Structural & Chemical Biology and Department of Chemistry, University of Leicester, Leicester, UK., Allain FHT; Institute of Biochemistry, ETH Zürich, Switzerland., Eperon IC; Leicester Institute of Structural & Chemical Biology and Department of Molecular & Cell Biology, University of Leicester, Leicester, UK.
Publikováno v:
The EMBO journal [EMBO J] 2022 Jan 04; Vol. 41 (1), pp. e107640. Date of Electronic Publication: 2021 Nov 15.
Autor:
Saifullah HH; Chester Medical School, University of Chester, Bache Hall, Chester CH2 1BR, UK., Lucas CM; Chester Medical School, University of Chester, Bache Hall, Chester CH2 1BR, UK.; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool L69 3GA, UK.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Aug 19; Vol. 13 (16). Date of Electronic Publication: 2021 Aug 19.
Autor:
Clark RE; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool L69 3GA, UK., Basabrain AA; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool L69 3GA, UK., Austin GM; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool L69 3GA, UK., Holcroft AK; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool L69 3GA, UK., Loaiza S; John Goldman Centre for Cellular Therapy, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London W12 0HS, UK., Apperley JF; Centre for Haematology, Imperial College London at Hammersmith Hospital, London W12 0HS, UK., Law C; Technology Directorate, University of Liverpool, Liverpool L69 3GA, UK., Scott L; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool L69 3GA, UK., Parry AD; Chester Medical School, University of Chester, Bache Hall, Chester CH2 1BR, UK., Bonnett L; Department of Biostatistics, University of Liverpool, Liverpool L69 3GA, UK., Lucas CM; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool L69 3GA, UK.; Chester Medical School, University of Chester, Bache Hall, Chester CH2 1BR, UK.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Apr 29; Vol. 13 (9). Date of Electronic Publication: 2021 Apr 29.